Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 02, 2026 08:00 ET | Source: Abinopharm, Inc.

Abinopharm, Inc. Releases AbinoNutra® NMN White Paper Following FDA Reinstatement and Human Clinical Trial Evidence

SHELTON, Conn., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Abinopharm, Inc., a U.S.-based life-science company headquartered in Shelton, Connecticut, today announced the publication of its newly released...
July 06, 2025 20:05 ET | Source: Abinopharm, Inc.

Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health

Human Clinical Trial of L-Ergothioneine (Dr.Ergo®) on Skin Health
March 24, 2025 15:35 ET | Source: Abinopharm, Inc.

Abinopharm, Inc. warmly congratulates partner company EGT Synbio on receiving no objection letter from the FDA for their GRAS notification of Dr.Ergo®Ergothioneine

Abinopharm, Inc. and our partner, EGT Synbio, announced our Ergothioneine ingredient received GRAS status from FDA, the 2nd GRAS for Ergothioneine in US.